Cargando…

Proteomics Discovery of Disease Biomarkers

Recent technological developments in proteomics have shown promising initiatives in identifying novel biomarkers of various diseases. Such technologies are capable of investigating multiple samples and generating large amount of data end-points. Examples of two promising proteomics technologies are...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahram, Mamoun, Petricoin, Emanuel F.
Formato: Texto
Lenguaje:English
Publicado: Libertas Academica 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688375/
https://www.ncbi.nlm.nih.gov/pubmed/19578516
_version_ 1782167702241017856
author Ahram, Mamoun
Petricoin, Emanuel F.
author_facet Ahram, Mamoun
Petricoin, Emanuel F.
author_sort Ahram, Mamoun
collection PubMed
description Recent technological developments in proteomics have shown promising initiatives in identifying novel biomarkers of various diseases. Such technologies are capable of investigating multiple samples and generating large amount of data end-points. Examples of two promising proteomics technologies are mass spectrometry, including an instrument based on surface enhanced laser desorption/ionization, and protein microarrays. Proteomics data must, however, undergo analytical processing using bioinformatics. Due to limitations in proteomics tools including shortcomings in bioinformatics analysis, predictive bioinformatics can be utilized as an alternative strategy prior to performing elaborate, high-throughput proteomics procedures. This review describes mass spectrometry, protein microarrays, and bioinformatics and their roles in biomarker discovery, and highlights the significance of integration between proteomics and bioinformatics.
format Text
id pubmed-2688375
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Libertas Academica
record_format MEDLINE/PubMed
spelling pubmed-26883752009-07-01 Proteomics Discovery of Disease Biomarkers Ahram, Mamoun Petricoin, Emanuel F. Biomark Insights Original Research Recent technological developments in proteomics have shown promising initiatives in identifying novel biomarkers of various diseases. Such technologies are capable of investigating multiple samples and generating large amount of data end-points. Examples of two promising proteomics technologies are mass spectrometry, including an instrument based on surface enhanced laser desorption/ionization, and protein microarrays. Proteomics data must, however, undergo analytical processing using bioinformatics. Due to limitations in proteomics tools including shortcomings in bioinformatics analysis, predictive bioinformatics can be utilized as an alternative strategy prior to performing elaborate, high-throughput proteomics procedures. This review describes mass spectrometry, protein microarrays, and bioinformatics and their roles in biomarker discovery, and highlights the significance of integration between proteomics and bioinformatics. Libertas Academica 2008-06-06 /pmc/articles/PMC2688375/ /pubmed/19578516 Text en © 2008 by the authors http://creativecommons.org/licenses/by/3.0 This article is published under the Creative Commons Attribution By licence. For further information go to: http://creativecommons.org/licenses/by/3.0. (http://creativecommons.org/licenses/by/3.0)
spellingShingle Original Research
Ahram, Mamoun
Petricoin, Emanuel F.
Proteomics Discovery of Disease Biomarkers
title Proteomics Discovery of Disease Biomarkers
title_full Proteomics Discovery of Disease Biomarkers
title_fullStr Proteomics Discovery of Disease Biomarkers
title_full_unstemmed Proteomics Discovery of Disease Biomarkers
title_short Proteomics Discovery of Disease Biomarkers
title_sort proteomics discovery of disease biomarkers
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688375/
https://www.ncbi.nlm.nih.gov/pubmed/19578516
work_keys_str_mv AT ahrammamoun proteomicsdiscoveryofdiseasebiomarkers
AT petricoinemanuelf proteomicsdiscoveryofdiseasebiomarkers